2.2. TMZ+AT101/AT101 Treatment Led to Phosphorylation of AKT, mTOR and GSK3ß, Resulting in Expression of Pro-Tumorigenic Genes in Surviving GBM Cells. The gene discussed is AKT1; the disease is glioblastoma.